|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Praxis Precision Medicines, Inc. (PRAX) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
52,390,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Praxis is a clinical-stage biopharmaceutical company that is engaged in developing therapies for central nervous system disorders characterized by neuronal imbalance. Co.'s lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and PRAX-944, a selective small molecule inhibitor of T-type calcium channels, which is in Phase IIa clinical trial for the treatment of essential tremor.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
24,500 |
165,502 |
Total Buy Value |
$0 |
$0 |
$35,962 |
$168,567 |
Total People Bought |
0 |
0 |
2 |
5 |
Total Buy Transactions |
0 |
0 |
2 |
8 |
Total Shares Sold |
0 |
0 |
0 |
8,000 |
Total Sell Value |
$0 |
$0 |
$0 |
$6,998 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
1 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Souza Marcio |
Chief Executive Officer |
|
2022-11-14 |
4 |
A |
$1.81 |
$3,830 |
D/D |
2,115 |
191,299 |
|
- |
|
Nemiroff Alex |
General Counsel and Secretary |
|
2022-11-14 |
4 |
A |
$1.81 |
$1,235 |
D/D |
682 |
40,029 |
|
- |
|
Mastrocola Lauren |
Principal Accounting Officer |
|
2022-06-16 |
4 |
B |
$1.93 |
$5,775 |
D/D |
3,000 |
31,391 |
2.74 |
- |
|
Kelly Timothy Edwin |
Chief Financial Officer |
|
2022-06-09 |
4 |
B |
$1.77 |
$17,650 |
D/D |
10,000 |
40,490 |
2.74 |
- |
|
Mastrocola Lauren |
Principal Accounting Officer |
|
2022-05-13 |
4 |
A |
$8.80 |
$22,496 |
D/D |
2,557 |
28,391 |
|
- |
|
Sweeny Nicole |
Chief Commercial Officer |
|
2022-05-13 |
4 |
A |
$8.80 |
$22,760 |
D/D |
2,587 |
42,154 |
|
- |
|
Kelly Timothy Edwin |
Chief Financial Officer |
|
2022-05-13 |
4 |
A |
$8.80 |
$22,743 |
D/D |
2,585 |
30,490 |
|
- |
|
Souza Marcio |
Chief Executive Officer |
|
2022-05-13 |
4 |
A |
$8.80 |
$12,247 |
D/D |
1,392 |
162,184 |
|
- |
|
Nemiroff Alex |
General Counsel and Secretary |
|
2022-05-13 |
4 |
A |
$8.80 |
$19,373 |
D/D |
2,202 |
31,847 |
|
- |
|
Sweeny Nicole |
Chief Commercial Officer |
|
2022-02-12 |
4 |
D |
$12.85 |
$15,844 |
D/D |
(1,233) |
39,567 |
|
- |
|
Mastrocola Lauren |
Principal Accounting Officer |
|
2022-02-12 |
4 |
D |
$12.85 |
$7,504 |
D/D |
(584) |
25,834 |
|
- |
|
Ravina Bernard |
Chief Medical Officer |
|
2022-02-12 |
4 |
D |
$12.85 |
$39,282 |
D/D |
(3,057) |
99,476 |
|
- |
|
Nemiroff Alex |
General Counsel and Secretary |
|
2022-02-12 |
4 |
D |
$12.85 |
$9,702 |
D/D |
(755) |
29,645 |
|
- |
|
Mastrocola Lauren |
Principal Accounting Officer |
|
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
26,418 |
|
- |
|
Ravina Bernard |
Chief Medical Officer |
|
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
102,533 |
|
- |
|
Nemiroff Alex |
General Counsel and Secretary |
|
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
30,400 |
|
- |
|
Sweeny Nicole |
Chief Commercial Officer |
|
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
40,800 |
|
- |
|
Souza Marcio |
President and CEO |
|
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
74,000 |
160,792 |
|
- |
|
Kelly Timothy Edwin |
Chief Financial Officer |
|
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
24,000 |
27,905 |
|
- |
|
Schwarzman Stephen A |
10% Owner |
|
2021-10-06 |
4 |
S |
$17.50 |
$7,000,000 |
I/I |
(400,000) |
0 |
|
- |
|
Schwarzman Stephen A |
10% Owner |
|
2021-10-05 |
4 |
S |
$19.15 |
$458,566 |
I/I |
(23,946) |
400,000 |
|
- |
|
Schwarzman Stephen A |
10% Owner |
|
2021-10-01 |
4 |
S |
$19.13 |
$432,338 |
I/I |
(22,600) |
423,946 |
|
- |
|
Kelly Timothy Edwin |
Chief Financial Officer |
|
2021-08-31 |
4 |
B |
$19.48 |
$76,069 |
D/D |
3,905 |
3,905 |
2.74 |
- |
|
Schwarzman Stephen A |
10% Owner |
|
2021-08-23 |
4 |
S |
$19.00 |
$6,696,326 |
I/I |
(352,396) |
446,546 |
|
- |
|
Schwarzman Stephen A |
10% Owner |
|
2021-08-18 |
4 |
S |
$15.88 |
$47,640 |
I/I |
(3,000) |
798,942 |
|
- |
|
77 Records found
|
|
Page 2 of 4 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|